Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • HeidiLee
    Member
    • Jul 2011
    • 20

    #1

    Bowtie Aligning failed 100%

    Hello,

    I am trying to use bowtie to align sanger human DNA reads on hg19. The command line I have used is:
    ./bowtie -p 1 -m 20 --best --sam hg19 ../Task/Source/454reads_test.fastq ../Task/Source/454reads_test.sam
    and I got the following report:
    # reads processed: 84205
    # reads with at least one reported alignment: 0 (0.00%)
    # reads that failed to align: 84205 (100.00%)
    No alignments

    The sequences seem unusually long, 300-400bases.
    And actually, I am not sure if I should use hg19 as prebuild index. There several indexes fir H. Sapian.

    Could any one please help me with this alignment?

    Thank you very much in advance.

    Heidi
    Last edited by HeidiLee; 08-05-2012, 01:46 AM.
  • HeidiLee
    Member
    • Jul 2011
    • 20

    #2
    I think I need to use BWA-SW for sequences with long lengths.
    I am still learning :0)

    Comment

    • arolfe
      Member
      • Jul 2011
      • 29

      #3
      Bowtie2, Blat, and Blast are also a possibilities.

      Whatever you choose, make sure you understand how it decides what to report. Bowtie was tuned for short reads, so it will not report matches if there are more than a few snps. It's also sensitive to where the snps fall in the read- snps at the 5' end are in the region it uses as an alignment seed and it can't handle more than 2 there.

      Bowtie2 lets you specify the minimum score to report a match in terms of the query length, which scales much better with increasing read lengths.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 02:55 AM
      0 responses
      4 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Working...